Dhaka, Bangladesh (BBN) – Three more listed companies – Kohinoor Chemicals Company, Pharma Aids and Orion Infusions have recommended dividend for the year ended on June 30, 2016, according to separate official disclosure on Wednesday.
Kohinoor Chemicals: The board of directors of Kohinoor Chemicals Company has recommended 10 percent cash and 20 percent stock dividend for the year ended on June 30, 2016, said an official disclosure on Wednesday.
The final approval will come during the annual general meeting (AGM) scheduled to be held on December 20. The record date for entitlement of dividend is on November 30.
The company has also reported earnings per share (EPS) of BDT 11.75, net asset value (NAV) per share of BDT 41.10 and net operating cash flow per share (NOCFPS) of BDT 12.25 for the year ended on June 30, 2016 as against BDT 9.01, BDT 32.35 and BDT 20.69 respectively for the same period of the previous year.
Each share of the company, which was listed on the Dhaka bourse in 1988, hovered between BDT 419.80 and BDT 445, before closing at BDT 425.60 on Tuesday.
The company’s paid-up capital is BDT101.56 million and authorised capital is BDT 500 million, while total number of securities is 10,156,250, according to statistics from the DSE.
The sponsor-directors own 48.72 percent stake in the company, while institutional investors own 11.85 percent, foreign 0.02 percent and the general public 39.41 percent as on September 29, 2016.
Pharma Aids: The board of directors of Pharma Aids has recommended 30 percent cash dividend for the year ended on June 30, 2016.
The final approval will come during the annual general meeting (AGM) scheduled to be held on December 29 at 11am at Segun Bagicha in Dhaka. The record date is on December 04.
The company has also reported earnings per share (EPS) of BDT 7.52, net asset value (NAV) per share of BDT 42.45 and net operating cash flow per share (NOCFPS) of BDT 3.89 for the year ended on June 30, 2016 as against BDT 8.16, BDT 37.43 and BDT 1.11 respectively for the same period of the previous year.
Each share of the company, which was listed on the Dhaka bourse in 1987, closed at BDT 244.40 on Tuesday.
The company’s paid-up capital is BDT 31.20 million and authorised capital is BDT 50 million, while total number of securities is 3,120,000, according to statistics from the DSE.
The sponsor-directors own 28.44 percent stake in the company, while institutional investors own 5.16 percent and the general public 66.40 percent as on September 29, 2016.
Orion Infusions: The board of directors of Orion Infusion has recommended 14 percent cash dividend for the year ended on June 30, 2016.
The final approval will come during the annual general meeting (AGM) scheduled to be held on December 20 at 11am at Officers’ Club in Dhaka.
The record date for entitlement of dividend is on November 30.
The company has also reported earnings per share (EPS) of BDT 5.25, net asset value (NAV) per share of BDT 12.98 and net operating cash flow per share (NOCFPS) of BDT 5.15 for the year ended on June 30, 2016 as against BDT 1.39, BDT 9.21 and BDT 3.41 respectively for the same period of the previous year.
Each share of the company, which was listed on the Dhaka bourse in 1994, hovered between BDT 68 and BDT 73, before closing at BDT 68.90 on Tuesday.
The company’s paid-up capital is BDT 203.59 million and authorised capital is BDT 1,000 million, while total number of securities is 20,359,760, according to statistics from the DSE.
The sponsor-directors own 40.61 percent stake in the company, while institutional investors own 28.26 percent, foreign 2.44 percent and the general public 28.69 percent as on September 29, 2016.
There will be no price limit on the trading of the shares of these three companies today following their corporate declarations.
BBN/AD/SR